Kevin Young CBE is an Executive VP at Gilead Sciences, a leading biotech firm. In 2011, he was appointed Commander of the British Empire in recognition of his service to the healthcare and pharmaceutical industries.
Young paid $8M for this house in 2012. The previous owner, Michael Thaxton, had the unique property featured in the New York Times. The article with photos is in the comment section below.
Residential
Links: www.gilead.com, www.nytimes.com
By: gordonhigh